CLINICAL_TRIALS
trial_result
· 2023-01-26
Clinical Trial Update: Ketamine to Prevent PPD After Cesarean [Phase 3]
Summary
A Phase 3 trial evaluated ketamine for prevention of postpartum depression after cesarean delivery; study completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Postpartum Depression | Phase 3 | Status: COMPLETED | Results posted: 2023-01-26